Company Profile
iSpecimen Stock Price, News & Analysis
- Ticker:
- ISPC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.20 USD (+14.58%)
Close
Last updated: August 6, 2026
4.41M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, ISPC closed up 14.6% at $2.20. No new same-company headline was identified in the current news window.
Company overview
Business overview
iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.
Geographic Base and Sector Classification
iSpecimen is headquartered in the United States and listed on NASDAQ. It sits in biotech infrastructure and research services.
Business Model Characteristics
The business depends on research demand, platform adoption, and the ability to connect buyers and sample providers efficiently. Investors track revenue growth, customer acquisition, and the health of research spending.
Position Within the Biotechnology Landscape
iSpecimen belongs in the infrastructure layer of the biotech ecosystem. It is not a drug developer, but it helps enable translational research and discovery.
Future catalysts
iSpecimen’s catalysts are biospecimen marketplace growth and research-customer adoption. The business improves when the platform becomes more embedded in sourcing workflows.
Recent news
- 01
iSpecimen Secures Suppliers for COVID-style hMPV Outbreak
Source: iSpecimen
- 02
iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens
Source: iSpecimen
- 03
- 04
iSpecimen Appoints Robert Lim as CEO and Director
Source: iSpecimen
- 05
iSpecimen Named Top Competitor in $4.4 Billion USD Market
Source: iSpecimen
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of iSpecimen (ISPC)?
iSpecimen (ISPC) most recently closed at 2.20 USD, a +14.58% move versus the previous session.
What is the market cap of iSpecimen (ISPC)?
iSpecimen currently has a market capitalization of 4.41M USD on BioPharmSignal.
What does iSpecimen do?
iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.
On which exchange is ISPC stock listed?
iSpecimen (ISPC) is associated with NASDAQ, United States, Biopharma.
What future catalysts are investors watching for iSpecimen?
iSpecimen’s catalysts are biospecimen marketplace growth and research-customer adoption. The business improves when the platform becomes more embedded in sourcing workflows.